Patent · US Active

Antibodies to the PcrV antigen of Pseudomonas aeruginosa

US8877191B2 · kind B2 · utility

0Cited by

7References

18Claims

0Family size

Assignee

KaloBios Pharmaceuticals, Inc. · US

Inventors

Christopher R. Bebbington · San Mateo, US
Kenneth Luehrsen · Rue de l'Église, US
Geoffrey T. Yarranton · Burlingame, US
Mark Baer · South San Francisco, US

Key dates

Filing date	Oct 11, 2011
Grant date	Nov 4, 2014
Priority date	—
Expiry date	Oct 11, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The current invention provides high-affinity antibodies to the Pseudomonas aeruginosa PcrV protein that have reduced immunogenicity when administered to treat Pseudomonas aeruginosa infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.